Delivery Order SPE2DR25D1110-SPE2DR26F12US
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lisdexamfetamine 40 mg capsules in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $1,480.44 and an ultimate completion date of August 7, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) with a ceiling value of $8,109.38. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a ceiling value of $3,887.69. This competitively awarded, firm fixed-price delivery order is set to complete by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) valued at $1,057.44. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The delivery order is due for completion by September 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) with a ceiling value of $1,204.49. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The contract is set to be completed by September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,437.63 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $6,184.82. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on September 12, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $14,087.04 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 70 mg capsules (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F12USDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count) with a contract value of $1,625.77 and an ultimate completion date of October 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is one of numerous pharmaceutical supply transactions executed under AmerisourceBergen's comprehensive global pharmaceutical support vehicle with the DLA. The company's federal contract portfolio encompasses a broad range of therapeutic categories including neurological treatments, pain management pharmaceuticals, diabetes medications, antibiotics, and specialty medical supplies. The Lisdexamfetamine supply supports the Defense Health Agency and other government healthcare systems' operational requirements. Place of performance for this delivery order is located in Conshohocken, Pennsylvania, where the contractor maintains its corporate office and distribution operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/21/25 |